VILINBIOPharmaceuticals
Vilin Bio Med Ltd — PE Ratio & Valuation Analysis
₹38.10
+0.00%
Current P/E118.30xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E26.1x353.3% above avg
⚠️
272.4% Premium to Industry
VILINBIO P/E 118.30x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2023 | ₹0.89 | ₹23 | 26.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Vilin Bio Med Ltd Valuation
Vilin Bio Med Ltd (VILINBIO) currently trades at 118.30x earnings. The Pharmaceuticals sector average PE is 31.77x. VILINBIO commands a premium, reflecting high growth expectations. Historically, VILINBIO has traded at an average PE of 26.1x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
0.96%
Dividend Yield
0.00%
More on Vilin Bio Med Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.